Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN65,1165,142,13
Msft-0,17
Nokia3,29053,2965-1,02
IBM0,08
Mercedes-Benz Group AG73,8573,870,39
PFE-0,11
29.03.2024 0:38:52
Indexy online
AD Index online
select
AD Index online
 

  • 28.03.2024 21:15:00
Becton Dickinson (BDX, NY Consolidated)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (ks)
247,45 0,37 0,92 1 092 485
After-hours29.03.2024 0:00:00
Poslední obchod Nákup / Prodej Změna (%) Změna (USD)
247,45 - - 0,37 0,92
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 29.03.2024
Popis společnosti
Obecné informace
Název společnostiBecton Dickinson and Co
TickerBDX
Kmenové akcie:Ordinary Shares
RICBDX
ISIN-
Prioritní akcieConv. Pref. Shrs
Prioritní akcieConv. Pref. Shrs Series B
Poslední známé roční výsledky30.09.2023
Poslední známé čtvrtletní výsledky31.12.2023
Počet zaměstnanců k 30.09.2023 73 000
Akcie v oběhu k 31.12.2023 288 902 232
MěnaUSD
Konstituent indexůS&P 500
Kontaktní informace
UliceOne Becton Drive
MěstoFRANKLIN LAKES
PSČ07417-1880
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon12 018 476 800

Business Summary: Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others. The Company's BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a wide range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, and pharmaceutical systems. The Company's BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
Financial Summary: BRIEF: For the three months ended 31 December 2023, Becton Dickinson and Co revenues increased 3% to $4.71B. Net income applicable to common stockholders decreased 42% to $281M. Revenues reflect Medical segment increase of 4% to $2.23B, Interventional segment increase of 5% to $1.19B, United States segment increase of 1% to $2.75B. Net income was offset by Restructuring costs increase from $26M to $69M (expense).
Odvětvová klasifikace
TRBC2009Medical Equipment / Supplies / Distribution
TRBC2012Medical Equipment, Supplies & Distribution (NEC)
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSSurgical and Medical Instrument Manufacturing
NAICSSurgical Appliance and Supplies Manufacturing
NAICSAnalytical Laboratory Instrument Manufacturing
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICS2007Surgical & Medical Instrument Mfg
NAICS2007Surgical Appliance & Supplies Mfg
NAICS2007Analytical Laboratory Instrument Mfg
NAICS2007Electromedical Apparatus Mfg
NAICS1997Surgical and Medical Instrument Manufacturing
NAICS1997Surgical Appliance and Supplies Manufacturing
NAICS1997Analytical Laboratory Instrument Manufacturing
NAICS1997Electromedical and Electrotherapeutic Apparatus Manufacturing
SICSurgical And Medical Instruments
SICSurgical And Medical Instruments
SICSurgical Appliances And Supplies
SICAnalytical Instruments
SICElectromedical Equipment



  • Poslední aktualizace: 29.03.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, President, Chief Executive OfficerThomas Polen5001.10.2014
Chief Financial Officer, Executive Vice PresidentChristopher DelOrefice5206.09.202106.09.2021
Executive Vice President, President - Life Sciences SegmentDavid Hickey6101.01.202101.01.2021
Chief People Officer, Executive Vice PresidentShana Neal58
Executive Vice President, President, North America, Chief Marketing OfficerAntoine Ezell54
Executive Vice President, General CounselMichelle Quinn55
Executive Vice President, President - Interventional SegmentRichard Byrd5606.09.202206.09.2022
Executive Vice President, President - Medical SegmentMichael Garrison5506.09.202206.09.2022
Executive Vice President, President - EMEARoland Goette61
Executive Vice President, President, Greater AsiaPavan Mocherla54